Pharmaceuticals

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

August 21, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Specialty Generics Market From 2025 to 2029?#_x000D_

The size of the specialty generics market has seen a fast-paced expansion in recent durations. The market, expected to rise from $95.87 billion in 2024, will further leap to $107.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.7%. Factors that have led to the growth in prior periods are the expiration of patents for proprietary drugs, a mounting demand for affordable options, supportive regulations for the approval of generic drugs, a significant increase in medical care costs, prevalence of chronic illnesses, and an aging demographic._x000D_

_x000D_

The market size of specialty generics is predicted to experience swift expansion in the following years, reaching an estimated value of $185.68 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. Factors contributing to this increase over the projected timeframe include the growth of the biosimilars market, the accentuation of complex generic drug development, heightened attention toward specialty generic injectables, the application of 3D printing in specialty generic creation, and the prospective market expansion in emerging countries. The future trends within this period are expected to encompass personalized and pinpointed specialty generics, strategic alliances, and partnerships in generic drug development. Additionally, emphasis on formulating abuse-deterrent medicines, incorporation of digital health technologies in specialty generics, and regulatory actions for quick approvals of complex generics are also projected._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Specialty Generics Market?#_x000D_

The increasing prevalence of chronic diseases are anticipated to fuel the demand for the specialty generic market. Chronic illnesses are persistent conditions that are typically incurable, albeit occasionally treatable and manageable. Factors such as lifestyle changes, dietary habits, and lack of weight control contribute to these chronic conditions, and certain chronic infections can also increase the risk of cancer. This rise in chronic disease incidence heightens the need for specialty generics to treat complex chronic conditions. For instance, in September 2022, data from the World Health Organization, a Switzerland-based arm of the United Nations, indicated that there were 41 million, or 74%, of global deaths each year resulting from non-communicable diseases (NCDs) or chronic diseases. These included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the rise in chronic diseases is fuelling the growth of the specialty generic market._x000D_

_x000D_

#Which Segments Are Detailed In The Global Specialty Generics Market Report?#_x000D_

The specialty generics market covered in this report is segmented – _x000D_

_x000D_

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration_x000D_

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication_x000D_

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx_x000D_

_x000D_

Subsegments:_x000D_

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables _x000D_

2) By Oral: Tablets, Capsules, Liquid Formulations _x000D_

3) By Other Route Of Administration: Topical, Transdermal, Inhalation _x000D_

_x000D_

#Which Emerging Trends And Strategic Shifts Are Shaping The Specialty Generics Market?#_x000D_

Leading firms in the specialty generic market are gaining approvals for substances like Lisdexamfetamine Dimesylate to fulfill the urgent medication need. Obtaining approval for specialty generics is indicative of an official sanction granted to pharmaceutical products, which are bioequivalent and offer the same therapeutic results as branded specialty drugs. These drugs are commonly used for treating intricate or rare health conditions following the expiry of patent protection. To illustrate, Mallinckrodt plc, a specialty pharmaceutical organization based in Ireland, procured FDA approval in August 2023 for its Lisdexamfetamine Dimesylate Capsules. This product, under the SpecGx LLC Specialty Generics division, is meant for treating Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate, a specific type of specialty generic, is a federally controlled substance (CII) utilized in the treatment of ADHD and other related conditions._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Specialty Generics Market?#_x000D_

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Specialty Generics Market By 2025?#_x000D_

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_